| Tumor necrosis factor α and regulatory T cells in oncoimmunology BL Salomon, M Leclerc, J Tosello, E Ronin, E Piaggio, JL Cohen Frontiers in immunology 9, 345465, 2018 | 184 | 2018 |
| Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells M Leclerc, S Naserian, C Pilon, A Thiolat, GH Martin, C Pouchy, ... Blood, The Journal of the American Society of Hematology 128 (12), 1651-1659, 2016 | 107 | 2016 |
| A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL N Schmitz, L Truemper, K Bouabdallah, M Ziepert, M Leclerc, G Cartron, ... Blood, The Journal of the American Society of Hematology 137 (19), 2646-2656, 2021 | 74 | 2021 |
| Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients A Maillard, R Redjoul, M Klemencie, H Labussière Wallet, A Le Bourgeois, ... Blood, The Journal of the American Society of Hematology 139 (1), 134-137, 2022 | 63 | 2022 |
| Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications P Hirsch, M Leclerc, M Rybojad, AD Petropoulou, M Robin, P Ribaud, ... Transplantation 93 (12), 1265-1269, 2012 | 61 | 2012 |
| Simple, reproducible, and efficient clinical grading system for murine models of acute graft-versus-host disease S Naserian, M Leclerc, A Thiolat, C Pilon, C Le Bret, Y Belkacemi, ... Frontiers in Immunology 9, 10, 2018 | 60 | 2018 |
| De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome G la Martire, C Robin, N Oubaya, R Lepeule, F Beckerich, M Leclerc, ... European Journal of Clinical Microbiology & Infectious Diseases 37, 1931-1940, 2018 | 58 | 2018 |
| Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the … J Gauthier, X Poiré, AC Gac, M Leclerc, T Guillaume, Y Chalandon, ... Bone marrow transplantation 53 (4), 400-409, 2018 | 43 | 2018 |
| Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors M Leclerc, S Fourati, D Menouche, D Challine, S Maury The Lancet Haematology 8 (3), e167-e169, 2021 | 34 | 2021 |
| Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases M Leclerc, F Suarez, MP Noël, A Vekhoff, X Troussard, JF Claisse, ... Annals of hematology 94, 89-95, 2015 | 27 | 2015 |
| Molecular demonstration of a Pneumocystis outbreak in stem cell transplant patients: evidence for transmission in the daycare center C Robin, A Alanio, M Gits-Muselli, G la Martire, F Schlemmer, F Botterel, ... Frontiers in microbiology 8, 700, 2017 | 26 | 2017 |
| Current preventions and treatments of aGVHD: from pharmacological prophylaxis to innovative therapies S Naserian, M Leclerc, S Shamdani, G Uzan Frontiers in Immunology 11, 607030, 2020 | 24 | 2020 |
| Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii C Robin, MP Lê, G Melica, L Massias, R Redjoul, N Khoudour, M Leclerc, ... Journal of Antimicrobial Chemotherapy 72 (9), 2602-2606, 2017 | 17 | 2017 |
| Toxoplasmosis as an early complication of allogeneic hematopoietic cell transplantation C Robin, M Leclerc, C Angebault, R Redjoul, F Beckerich, L Cabanne, ... Biology of Blood and Marrow Transplantation 25 (12), 2510-2513, 2019 | 16 | 2019 |
| Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab M Leclerc, JFÇ Lesesve, B Gaillard, X Troussard, A Tourbah, ... Leukemia & Lymphoma 52 (5), 910-912, 2011 | 14 | 2011 |
| Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients M Leclerc, R Redjoul, A Le Bouter, F Beckerich, C Robin, V Parinet, ... Journal of Hematology & Oncology 15 (1), 27, 2022 | 13 | 2022 |
| Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT M Leclerc, R Redjoul, A Le Bouter, F Beckerich, C Robin, V Parinet, ... The Lancet Haematology 9 (5), e318-e321, 2022 | 12 | 2022 |
| Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease L Boucault, MD Lopez Robles, A Thiolat, S Bézie, ... Blood Advances 4 (11), 2501-2515, 2020 | 12 | 2020 |
| Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm? M Leclerc, R Peffault de Latour, M Michallet, D Blaise, P Chevallier, ... Blood, The Journal of the American Society of Hematology 129 (9), 1227-1230, 2017 | 12 | 2017 |
| TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation A Moatti, A Debesset, C Pilon, A Beldi-Ferchiou, M Leclerc, R Redjoul, ... Journal for Immunotherapy of Cancer 10 (4), 2022 | 11 | 2022 |
